Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -773.1%
March 31, 2026 -650.8%
December 31, 2025 -3.29K%
September 30, 2025 -2.69K%
June 30, 2025 -1.20K%
March 31, 2025 -426.3%
December 31, 2024 -308.6%
September 30, 2024 -673.8%
June 30, 2024
March 31, 2024 -483.4%
December 31, 2023 -126.8%
September 30, 2023 -463.7%
June 30, 2023 -106.7%
March 31, 2023 12.51%
December 31, 2022 -73.04%
September 30, 2022 -18.67%
June 30, 2022 -26.18%
March 31, 2022 -28.63%
December 31, 2021 -113.3%
September 30, 2021 -148.3%
June 30, 2021 -202.7%
March 31, 2021 -56.79%
December 31, 2020 -297.5%
September 30, 2020 -1.31K%
June 30, 2020 -762.5%
Date Value
March 31, 2020 -534.1%
December 31, 2019 -420.3%
September 30, 2019 -73.74%
June 30, 2019 -71.97%
March 31, 2019 -345.1%
December 31, 2018 -365.7%
September 30, 2018 -290.7%
June 30, 2018 -284.1%
March 31, 2018 -205.6%
December 31, 2017 -491.5%
September 30, 2017 -249.2%
June 30, 2017 -145.3%
March 31, 2017 -378.7%
December 31, 2016 -438.7%
September 30, 2016 -147.6%
June 30, 2016 -515.7%
March 31, 2016 -604.8%
December 31, 2015 -221.0%
September 30, 2015 -12.46%
June 30, 2015 -73.68%
March 31, 2015 -124.2%
December 31, 2014 -630.4%
September 30, 2014 -326.2%
June 30, 2014 -228.1%
March 31, 2014 -431.7%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. --
HealthEquity, Inc. 18.71%
SCWorx Corp. -17.14%
Health Catalyst, Inc. -57.51%
Diaceutics Plc --